172 related articles for article (PubMed ID: 11192938)
1. Anti-microinflammatory lipid signals generated from dietary N-3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and N-3 PUFA therapeutic actions.
Serhan CN; Clish CB; Brannon J; Colgan SP; Gronert K; Chiang N
J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):643-54. PubMed ID: 11192938
[TBL] [Abstract][Full Text] [Related]
2. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing.
Serhan CN; Clish CB; Brannon J; Colgan SP; Chiang N; Gronert K
J Exp Med; 2000 Oct; 192(8):1197-204. PubMed ID: 11034610
[TBL] [Abstract][Full Text] [Related]
3. Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics.
Serhan CN; Chiang N
Rheum Dis Clin North Am; 2004 Feb; 30(1):69-95. PubMed ID: 15061569
[TBL] [Abstract][Full Text] [Related]
4. Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA.
Chiang N; Takano T; Clish CB; Petasis NA; Tai HH; Serhan CN
J Pharmacol Exp Ther; 1998 Nov; 287(2):779-90. PubMed ID: 9808710
[TBL] [Abstract][Full Text] [Related]
5. Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin.
Fiorucci S; Distrutti E; Mencarelli A; Morelli A; Laufor SA; Cirino G; Wallace JL
Br J Pharmacol; 2003 Aug; 139(7):1351-9. PubMed ID: 12890715
[TBL] [Abstract][Full Text] [Related]
6. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
Serhan CN
Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201
[TBL] [Abstract][Full Text] [Related]
7. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells.
Papayianni A; Serhan CN; Brady HR
J Immunol; 1996 Mar; 156(6):2264-72. PubMed ID: 8690917
[TBL] [Abstract][Full Text] [Related]
8. Cooperation between aspirin-triggered lipoxin and nitric oxide (NO) mediates antiadhesive properties of 2-(Acetyloxy)benzoic acid 3-(nitrooxymethyl)phenyl ester (NCX-4016) (NO-aspirin) on neutrophil-endothelial cell adherence.
Fiorucci S; Distrutti E; Mencarelli A; Rizzo G; Lorenzo AR; Baldoni M; Del Soldato P; Morelli A; Wallace JL
J Pharmacol Exp Ther; 2004 Jun; 309(3):1174-82. PubMed ID: 14762100
[TBL] [Abstract][Full Text] [Related]
9. Novel omega -- 3-derived local mediators in anti-inflammation and resolution.
Serhan CN
Pharmacol Ther; 2005 Jan; 105(1):7-21. PubMed ID: 15626453
[TBL] [Abstract][Full Text] [Related]
10. Gastritis increases resistance to aspirin-induced mucosal injury via COX-2-mediated lipoxin synthesis.
Souza MH; de Lima OM; Zamuner SR; Fiorucci S; Wallace JL
Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G54-61. PubMed ID: 12637254
[TBL] [Abstract][Full Text] [Related]
11. Lipoxins, leukocyte recruitment and the resolution phase of acute glomerulonephritis.
O'Meara YM; Brady HR
Kidney Int Suppl; 1997 Mar; 58():S56-61. PubMed ID: 9067945
[TBL] [Abstract][Full Text] [Related]
12. Cell-cell interaction in the transcellular biosynthesis of novel omega-3-derived lipid mediators.
Chiang N; Serhan CN
Methods Mol Biol; 2006; 341():227-50. PubMed ID: 16799203
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion.
Bagga D; Wang L; Farias-Eisner R; Glaspy JA; Reddy ST
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1751-6. PubMed ID: 12578976
[TBL] [Abstract][Full Text] [Related]
14. Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation.
Wallace JL; Zamuner SR; McKnight W; Dicay M; Mencarelli A; del Soldato P; Fiorucci S
Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G76-81. PubMed ID: 14665439
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX.
Chiang N; Arita M; Serhan CN
Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):163-77. PubMed ID: 16125378
[TBL] [Abstract][Full Text] [Related]
16. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
[TBL] [Abstract][Full Text] [Related]
17. Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease.
Pouliot M; Clish CB; Petasis NA; Van Dyke TE; Serhan CN
Biochemistry; 2000 Apr; 39(16):4761-8. PubMed ID: 10769133
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1.
Seki H; Tani Y; Arita M
Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):126-30. PubMed ID: 19737659
[TBL] [Abstract][Full Text] [Related]
19. Lipoxins and new lipid mediators in the resolution of inflammation.
Schwab JM; Serhan CN
Curr Opin Pharmacol; 2006 Aug; 6(4):414-20. PubMed ID: 16750421
[TBL] [Abstract][Full Text] [Related]
20. Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin.
Fiorucci S; Distrutti E; de Lima OM; Romano M; Mencarelli A; Barbanti M; Palazzini E; Morelli A; Wallace JL
FASEB J; 2003 Jun; 17(9):1171-3. PubMed ID: 12709408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
